Notably, gene set variation analysis (GSVA) of a public microarray dataset (GEO: GSE9329139; 123 R-CHOP-treated MCL cases) revealed that decreased NF-κB signaling was significantly associated with poorer patient outcomes, while elevated MYC signaling showed a similar trend (Figure 2E). Here, MYC is linked to mantle cell lymphoma.